cyclohexanol has been researched along with Brain Ischemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, X; Fang, S; He, J; Kong, J; Li, XM; Wang, D; Wu, J; Xu, H; Yan, B; Yang, Y; Zhang, Y | 1 |
| Gerace, E; Landucci, E; Moroni, F; Pellegrini-Giampietro, DE; Scartabelli, T | 1 |
| Fowler, CJ; Rojo, ML; Söderström, I | 1 |
| Berger, C; Kuhnert, K; Müller, HD; Schäbitz, WR; Schomacher, M; Schwab, S; Sommer, C | 1 |
| Braida, D; Pozzi, M; Sala, M | 1 |
| De Vry, J; Horváth, E; Mauler, F; Mittendorf, J | 1 |
6 other study(ies) available for cyclohexanol and Brain Ischemia
| Article | Year |
|---|---|
Chronic effects of venlafaxine on synaptophysin and neuronal cell adhesion molecule in the hippocampus of cerebral ischemic mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain Ischemia; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hippocampus; Male; Mice; Neural Cell Adhesion Molecule L1; Neuronal Plasticity; Selective Serotonin Reuptake Inhibitors; Synaptophysin; Time Factors; Venlafaxine Hydrochloride | 2010 |
CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices.
Topics: Analysis of Variance; Animals; Arachidonic Acids; Benzoxazines; Brain Ischemia; Cannabinoids; Cyclohexanols; Gerbillinae; Glucose; Hippocampus; Hypoxia; Morpholines; Naphthalenes; Neurons; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2011 |
Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats.
Topics: Animals; Autoradiography; Brain; Brain Ischemia; Cyclohexanols; Disease Models, Animal; Estradiol; Estrogens; Female; Functional Laterality; Gene Expression Regulation; Guanosine 5'-O-(3-Thiotriphosphate); Infarction, Middle Cerebral Artery; Piperidines; Protein Binding; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Sulfur Isotopes; Time Factors; Tritium | 2011 |
Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra.
Topics: Animals; Autoradiography; Binding, Competitive; Brain Ischemia; Cyclohexanols; Dizocilpine Maleate; Down-Regulation; Excitatory Amino Acid Antagonists; Male; Neuroprotective Agents; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rimonabant | 2006 |
CP 55,940 protects against ischemia-induced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils.
Topics: Analgesics; Animals; Brain; Brain Ischemia; Cyclohexanols; Electroencephalography; Gerbillinae; Hyperkinesis; Male; Neuroprotective Agents; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2000 |
Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties.
Topics: Animals; Binding, Competitive; Body Temperature; Brain Injuries; Brain Ischemia; Cyclohexanols; Discrimination, Psychological; Guanosine 5'-O-(3-Thiotriphosphate); Hematoma, Subdural; Indans; Male; Middle Cerebral Artery; Neuroprotective Agents; Rats; Rats, Long-Evans; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction; Succinate Dehydrogenase; Sulfonic Acids | 2002 |